Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: A randomized, double-blind, placebo-controlled crossover trial

Journal of Clinical Psychiatry

Volumn 59, Issue 2, 1998, Pages 76-80

  Young, Stephen A ^a,b   Hurt, Peyton H ^a   Benedek, David M ^a   Howard, Robin S ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BUSPIRONE; DANAZOL; FLUOXETINE; NORTRIPTYLINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DYSPHORIA; FEMALE; HUMAN; LUTEAL PHASE; NAUSEA; NERVOUSNESS; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031952365     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v59n0206     Document Type: Article

References (35)

1. Tucker JS, Whalen RE. Premenstrual syndrome. Int J Psychiatry Med 1991;21:311-341
2. Logue C, Moos R. Perimenstrual symptoms: prevalence and risk factors. Psychosom Med 1986;48:388-414
3. Severino SK, Moline ML. Premenstrual syndrome. Obstet Gynecol Clin North Am 1990;17:889-903
4. Schmidt PJ, Grover GN, Rubinow DR. Alprazolam in the treatment of premenstrual syndrome. Arch Gen Psychiatry 1993;50:467-473
5. Elks ML. Open trial of fluoxetine therapy for premenstrual syndrome. South Med J 1993;86:503-507
6. Wood SH, Mortola JF. Treatment of premenstrual syndrome with fluoxetine: a double blind, placebo controlled, crossover study. Obstet Gynecol 1992;80:339-344
7. Jacobsen FM. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome. J Clin Psychiatry 1993;54:229-234
8. Daamen MJ, Brown WA. Single-dose fluoxetine in management of premenstrual syndrome [letter]. J Clin Psychiatry 1992;53:210-211
9. Derzko CM. Role of danazol in relieving the premenstrual syndrome. J Reprod Med 1990;35(suppl 1):97-102
10. Harrison WM, Endicott J, Nee J. Treatment of premenstrual depression with nortriptyline: a pilot study. J Clin Psychiatry 1989;50:136-139
11. Parry BL, Mahan AM, Mostofi N, et al. Light therapy of late luteal phase dysphoric disorder: an extended study. Am J Psychiatry 1993;150: 1417-1419
12. Rapkin AJ, Edelmuth E, Chang LC, et al. Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol 1987;70:533-537
13. Seifer DB, Collins RL. Current concepts of β-endorphin physiology in female reproductive dysfunction. Fertil Steril 1990;54:757-771
14. Chihal HJ. Premenstrual syndrome: an update for the clinician. Obstet Gynecol Clin North Am 1990;17:457-479
15. Lurie S, Borenstein R. The premenstrual syndrome. Obstet Gynecol Surv 1990;45:220-228
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987:367-369
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994:715-718
18. Menkes DB, Taghavi E, Mason PA, et al. Fluoxetine treatment of severe premenstrual syndrome. BMJ 1992;305:346-347
19. Stone AB, Pearlstein TB, Brown WA. Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1991;52:290-293
20. Rickels K, Freeman EW, Sondheimer S, et al. Fluoxetine in the treatment of premenstrual syndrome. Current Therapeutic Research 1990;48: 161-166
21. Steiner M, Steinberg S, Stewart D, et al. Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med 1995;332:1529-1534
22. Rickels K. Buspirone in treatment of premenstrual syndrome [letter]. Lancet 1989;1:777
23. Muse KN, Cetel NS, Futterman LA, et al. The premenstrual syndrome: effects of "medical ovariectomy." N Engl J Med 1984;311:1345-1349
24. Yonkers KA, Halbreich U, Freeman E, et al. Sertraline in the treatment of premenstrual dysphoric disorder. Psychopharmacol Bull 1996;32:41-46
25. Mortola JF, Girton L, Beck L, et al. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the Calendar of Premenstrual Experiences. Obstet Gynecol 1990;76:302-307
26. Hamilton JA, Parry BL, Alagna S, et al. Premenstrual mood changes: a guide to evaluation and treatment. Psychiatric Annals 1984;14:426-435
27. Ferin M, Jewelewicz R, Warren M. The Menstrual Cycle: Physiology, Reproductive Disorders, and Infertility. New York, NY: Oxford University Press; 1993:20-23
28. Giannini AJ, Melemis SM, Marin DM, et al. Symptoms of premenstrual syndrome as a function of beta-endorphin: two subtypes. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:321-327
29. Facchinetti F, Fioroni L, Martignoni E, et al. Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome. Psychosom Med 1994;56:418-422
30. Chuong CJ, Hsi BP, Gibbons WE. Periovulatory beta-endorphin levels in premenstrual syndrome. Obstet Gynecol 1994;83(5 pt 1):755-760
31. Chuong CJ, Hsi BP. Effect of naloxone on luteinizing hormone secretion in premenstrual syndrome. Fertil Steril 1994;61:1039-1044
32. Halbreich U, Tworek H. Altered serotonergic activity in women with dysphoric premenstrual syndrome. Int J Psychiatry Med 1993;23:1-27
33. Menkes DB, Coates DC, Fawcett JP. Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord 1994;32:37-44
34. Preskom S. Recent pharmacologic advances in antidepressant therapy for the elderly. Am J Med 1993;94(suppl 5A):2-12
35. Murdoch D, McTavish D. Sertraline: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Drugs 1992;44:604-624